High Cancer Inflammation Prognostic Index Identifies Patients With Stage II Colorectal Cancer With Outcomes Comparable to Stage III
Background: Risk stratification after curative resection remains challenging in stage II-III colorectal cancer (CRC). The cancer inflammation prognostic index (CIPI) has been proposed as a novel prognostic marker; however, whether high-risk stage II disease, as defined by CIPI, has outcomes comparable to those of stage...